Monopar's pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease NORTH CHICAGO, Ill., Jan. 23, 2025 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science announced that Monopar...
Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics
Seeking Alpha / 11 hours ago 1 Views
Comments